Phase 1 study of pomalidomide MTD , safety , and ef fi cacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib
Richardson, Paul G, Siegel, David, Baz, Rachid, Kelley, Susan L, Munshi, Nikhil C, Laubach, Jacob, Sullivan, Daniel, Alsina, Melissa, Schlossman, Robert, Ghobrial, Irene M, Doss, Deborah, Loughney, NoVolume:
121
Year:
2014
Language:
english
DOI:
10.1182/blood-2012-08-450742.There
File:
PDF, 652 KB
english, 2014